Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect
- 3 February 1996
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 347 (8997) , 295-297
- https://doi.org/10.1016/s0140-6736(96)90468-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Genotypic and phenotypic determination of polymorphic glutathione transferase T1 in a Swedish populationPharmacogenetics, 1995
- Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onsetCarcinogenesis: Integrative Cancer Research, 1995
- Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase thetaCarcinogenesis: Integrative Cancer Research, 1995
- Molecular cloning of a cDNA and chromosomal localization of a human theta-class glutathione S-transferase gene (GSTT2) to chromosome 22Genomics, 1995
- Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smokingCarcinogenesis: Integrative Cancer Research, 1994
- Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumoursThe Lancet, 1994
- Genetic Risk and Carcinogen Exposure: a Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1 (GSTM1) That Increases Susceptibility to Bladder CancerJNCI Journal of the National Cancer Institute, 1993
- Is environmental carcinogenesis modulated by host polymorphism?Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- The myelodysplastic syndromesBlood Reviews, 1987